Memorial Şişli Hospital
Il medico si è laureato presso la Scuola Medica GATA e ha completato la formazione specialistica in medicina interna e nefrologia presso l'Ospedale di Formazione GATA Haydarpaşa a Istanbul. Dal 2010, il medico lavora come specialista in medicina interna e nefrologo presso il Centro Medico Anadolu. Il medico è membro di diverse organizzazioni prestigiose, tra cui la Società Turca di Nefrologia, l'Associazione Europea di Nefrologia-Associazione Europea di Dialisi e Trapianto, e la Società Internazionale di Nefrologia.<\/p>
Dr. Cahide Yilmaz is a pediatric neurologist at NP Istanbul Brain Hospital. She is dually certified in general pediatrics and pediatric neurology. Dr. Yilmaz focuses on brain health and developmental disorders in children. She works at Turkey’s first private neuropsychiatric hospital, which holds JCI accreditation.
Dr. Özcan Uzun is a nephrology specialist at Medicalpoint International Hospital in İzmir. He treats complex kidney conditions, including diabetic kidney disease and glomerulonephritis. Dr. Uzun earned his medical degree from Atatürk University. He completed his internal medicine and nephrology training at Dokuz Eylül University. He is a member of the Turkish Nephrology Association and the Izmir Medical Chamber.
Dr. Mehmet Tekin Akpolat is a nephrologist at Liv Hospital Ulus in Istanbul. He specializes in chronic kidney disease and hypertension management. Dr. Akpolat completed a fellowship at the Baylor College of Medicine in Houston. He has authored over 15 books for patients and medical professionals.
Foreign patients can receive kidney transplants in Turkey through living donation only. Turkish law prohibits non-citizens from accessing the national deceased donor list. Success rates reach 96% for live donors at JCI-accredited centers. Legal relatives up to the fourth degree are eligible donors.
Bookimed Expert Insight: Success in Turkey depends on documentation over dollars. While many seek surgery for its 90% success rate, the real hurdle is the Ethics Committee review for non-relative donors. Clinics like Memorial Şişli or Anadolu Medical Center require verified proof of a 3-5 year relationship if the donor is not immediate family. Bringing a donor with a clear medical history from home speeds up the hospital's evaluation process significantly.
Patient Consensus: Patients note that hospitals scrutinize donor relationships intensely to ensure everything is legal. Most emphasize that you must have long-term follow-up care and immunosuppression medications arranged in your home country before traveling.
Patients should plan to remain in Turkey for 4 to 8 weeks after a kidney transplant. This period ensures the new organ functions correctly and allows for medication stabilization. Frequent monitoring at JCI-accredited facilities helps specialists detect early rejection signs before international travel.
Bookimed Expert Insight: High-volume centers like Medipol Mega University Hospital, serving over 1,000,000 patients annually, use this extended window to manage complex cases. While Memorial Şişli Hospital reports a 90% success rate, the critical factor is staying until creatinine levels and urine output stabilize. Clinics in Istanbul often coordinate with nearby hotels to accommodate this recovery phase.
Patient Consensus: Patients emphasize the need for flexibility, as fatigue and medication adjustments often take longer than expected. Most advise against booking return flights until the surgical team confirms the kidney is stable.
International kidney transplants in Turkey follow a regulated process centered on living donation. The journey begins with remote records review, followed by legal donor verification and clinical compatibility tests. Procedures occur in JCI-accredited centers where specialized urologists and nephrologists perform laparoscopic donor nephrectomies and recipient transplantations.
Bookimed Expert Insight: Memorial Şişli Hospital maintains a 90% organ transplant success rate and was the first in Turkey to earn JCI accreditation. Data shows top-tier centers like Medipol Mega serve over 1,000,000 patients annually because they offer specialized pediatric and adult transplant units. Choosing these high-volume academic hospitals ensures access to advanced technologies like the Da Vinci Surgical System for complex cases.
Patient Consensus: Patients note that administrative bottlenecks like document authentication and translation often take more time than the medical tests. Many emphasize that the compatibility workup can stop the process even after travel is booked.
Turkish nephrologists and transplant surgeons are highly experienced in managing complex chronic kidney disease and high-risk transplants. Major JCI-accredited centers in Istanbul achieve transplant success rates of 90%. Specialists often hold fellowships from prestigious US institutions like the Cleveland Clinic or Baylor College of Medicine.
Bookimed Expert Insight: Turkish kidney care stands out because top professors like Dr. Mehmet Tekin Akpolat and Dr. Suleyman Tevfik Ecder are not just surgeons. They are researchers with US clinical training. This academic depth is why clinics like Anadolu Medical Center maintain affiliations with Johns Hopkins Hospital. Our data shows these high-volume centers manage over 200,000 patients annually. This massive scale ensures even rare complications are familiar to the surgical teams.
Patient Consensus: Patients find Turkish hospitals highly organized and responsive regarding logistics. They emphasize that while marketing is common, the speed of coordination for foreign cases is a major practical advantage.
Istanbul, Ankara, and Izmir are Turkey's primary hubs for chronic kidney disease and renal-transplant care. Istanbul leads with the highest concentration of JCI-accredited facilities. These centers report 90% to 95% success rates for kidney transplants. Major institutions specialize in living-donor procedures and complex nephrology.
Bookimed Expert Insight: Istanbul remains the dominant choices due to sheer volume. Medipol Mega University Hospital alone manages 1,000,000 patients yearly. This massive scale often translates into higher clinical proficiency for rare kidney complications. Smaller hubs like Izmir offer the same JCI-standard care but with significantly less urban congestion for recovery.
Patient Consensus: Patients note that while Istanbul has the most options, the surgeon's specific case volume is more important than the city. Many emphasize checking for English-speaking coordinators and detailed plans for long-term immunosuppression management before traveling.